| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |